BioCentury | Jun 11, 2012
Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica computational chemistry/biology news

...chemistry. Details were not disclosed (see BioCentury, July 4, 2011). Biolauncher Ltd. , Cambridge, U.K. Cresset Biomolecular Discovery Ltd....
BioCentury | Aug 29, 2011
Company News

Cresset Biomolecular Discovery, Redx Pharma deal

...treat influenza infection and statin compounds in preclinical testing to increase high-density lipoprotein/low-density lipoprotein ratio. Cresset Biomolecular Discovery Ltd....
BioCentury | Jul 4, 2011
Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica deal

...display technology in the new platform. Details were not disclosed. Biolauncher Ltd. , Cambridge, U.K. Cresset Biomolecular Discovery Ltd....
BioCentury | Feb 2, 2009
Company News

Cresset BioMolecular Discovery Ltd., e-Therapeutics deal

...initial focus on pain. The companies will share resulting IP. Further terms were not disclosed. Cresset BioMolecular Discovery Ltd....
BioCentury | Sep 10, 2007
Company News

Galapagos sales and marketing update

...that transient receptor potential (TRP) channels. The FieldFocus libraries were created using FieldPrint technology from Cresset BioMolecular Discovery Ltd....
BioCentury | Jan 30, 2006
Company News

Cresset BioMolecular Discovery Ltd., Bayer deal

...use Cresset's FieldScreen in silico screening software to identify agrochemicals. Further terms were not disclosed. Cresset BioMolecular Discovery Ltd....
BioCentury | Dec 19, 2005
Company News

Galapagos NV, Cresset BioMolecular Discovery Ltd. deal

...Templater identifies the 3-dimensional conformation of compounds bound to targets. Galapagos NV (Euronext:GLPG), Mechelen, Belgium Cresset BioMolecular Discovery Ltd....
BioCentury | Dec 5, 2005
Company News

Cresset BioMolecular Discovery Ltd. sales and marketing update

...Field Templater in silico technology to identify the 3-dimensional conformation of therapeutics bound to targets. Cresset BioMolecular Discovery Ltd....
BioCentury | Mar 7, 2005
Company News

Cresset BioMolecular Discovery Ltd., Pharmagene deal

...technology to identify leads against an undisclosed target from PGN. Financial terms were not disclosed. Cresset BioMolecular Discovery Ltd....
BioCentury | Dec 13, 2004
Company News

Cresset BioMolecular Discovery Ltd. sales and marketing update

...for in silico screening of compound libraries based on molecular fields instead of molecular structure. Cresset BioMolecular Discovery Ltd....
Items per page:
1 - 10 of 10
BioCentury | Jun 11, 2012
Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica computational chemistry/biology news

...chemistry. Details were not disclosed (see BioCentury, July 4, 2011). Biolauncher Ltd. , Cambridge, U.K. Cresset Biomolecular Discovery Ltd....
BioCentury | Aug 29, 2011
Company News

Cresset Biomolecular Discovery, Redx Pharma deal

...treat influenza infection and statin compounds in preclinical testing to increase high-density lipoprotein/low-density lipoprotein ratio. Cresset Biomolecular Discovery Ltd....
BioCentury | Jul 4, 2011
Company News

Biolauncher, Cresset Biomolecular Discovery, Isogenica deal

...display technology in the new platform. Details were not disclosed. Biolauncher Ltd. , Cambridge, U.K. Cresset Biomolecular Discovery Ltd....
BioCentury | Feb 2, 2009
Company News

Cresset BioMolecular Discovery Ltd., e-Therapeutics deal

...initial focus on pain. The companies will share resulting IP. Further terms were not disclosed. Cresset BioMolecular Discovery Ltd....
BioCentury | Sep 10, 2007
Company News

Galapagos sales and marketing update

...that transient receptor potential (TRP) channels. The FieldFocus libraries were created using FieldPrint technology from Cresset BioMolecular Discovery Ltd....
BioCentury | Jan 30, 2006
Company News

Cresset BioMolecular Discovery Ltd., Bayer deal

...use Cresset's FieldScreen in silico screening software to identify agrochemicals. Further terms were not disclosed. Cresset BioMolecular Discovery Ltd....
BioCentury | Dec 19, 2005
Company News

Galapagos NV, Cresset BioMolecular Discovery Ltd. deal

...Templater identifies the 3-dimensional conformation of compounds bound to targets. Galapagos NV (Euronext:GLPG), Mechelen, Belgium Cresset BioMolecular Discovery Ltd....
BioCentury | Dec 5, 2005
Company News

Cresset BioMolecular Discovery Ltd. sales and marketing update

...Field Templater in silico technology to identify the 3-dimensional conformation of therapeutics bound to targets. Cresset BioMolecular Discovery Ltd....
BioCentury | Mar 7, 2005
Company News

Cresset BioMolecular Discovery Ltd., Pharmagene deal

...technology to identify leads against an undisclosed target from PGN. Financial terms were not disclosed. Cresset BioMolecular Discovery Ltd....
BioCentury | Dec 13, 2004
Company News

Cresset BioMolecular Discovery Ltd. sales and marketing update

...for in silico screening of compound libraries based on molecular fields instead of molecular structure. Cresset BioMolecular Discovery Ltd....
Items per page:
1 - 10 of 10